

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : 7-Methylxanthine
Therapeutic Area : Ophthalmology
Study Phase : Phase II
Sponsor : LifeSci Consulting
Deal Size : Undisclosed
Deal Type : Agreement
Details : Through the agreement, LifeSci will present 7-MX (7-methylxanthine), a first-in-class oral therapy for the treatment and management of Myopia progression in children, to potential partners.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Undisclosed
April 03, 2023
Lead Product(s) : 7-Methylxanthine
Therapeutic Area : Ophthalmology
Highest Development Status : Phase II
Sponsor : LifeSci Consulting
Deal Size : Undisclosed
Deal Type : Agreement
